UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

In vitro models for the blood–brain barrier

Toxicology in vitro, 2005-04, Vol.19 (3), p.299-334

2005

Volltextzugriff (PDF)

Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models

Pharmaceutical research, 2002-07, Vol.19 (7), p.976-981

2002

Volltextzugriff (PDF)

Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier

The Journal of pharmacology and experimental therapeutics, 1999-12, Vol.291 (3), p.1017

1999

Volltextzugriff (PDF)

Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.745

2004

Volltextzugriff (PDF)

In vitro model for evaluating drug transport across the blood–brain barrier

Advanced drug delivery reviews, 1999-04, Vol.36 (2), p.165-178

1999

Volltextzugriff (PDF)

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Pharmaceutical research, 1999-12, Vol.16 (12), p.1836-1842

1999

Volltextzugriff (PDF)

Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier

Pharmacological research, 2007-07, Vol.56 (1), p.11-17

2007

Volltextzugriff (PDF)

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier

The Journal of pharmacology and experimental therapeutics, 2004-12, Vol.311 (3), p.1115

2004

Volltextzugriff (PDF)

Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid

Molecular neurobiology, 2016-07, Vol.53 (5), p.3205-3215

2016

Volltextzugriff (PDF)

Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

Pharmaceutical research, 2004-05, Vol.21 (5), p.756-760

2004

Volltextzugriff (PDF)

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model

Brain research, 2009-01, Vol.1249, p.34-42

2009

Volltextzugriff (PDF)

Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro

Journal of lipid research, 1998-09, Vol.39 (9), p.1816-1824

1998

Volltextzugriff (PDF)

Mouse syngenic in vitro blood-brain barrier model : a new tool to examine inflammatory events in cerebral endothelium

Laboratory investigation, 2005-06, Vol.85 (6), p.734-746

2005

Volltextzugriff (PDF)

Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier

Brain research, 2004-08, Vol.1018 (1), p.1-9

2004

Volltextzugriff (PDF)

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening

Toxicology in vitro, 2008-04, Vol.22 (3), p.799-811

2008

Volltextzugriff (PDF)

High transcytosis of melanotransferrin (P97) across the blood–brain barrier

Journal of neurochemistry, 2002-11, Vol.83 (4), p.924-933

2002

Volltextzugriff (PDF)

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood-Brain Barrier

The Journal of cell biology, 1997-08, Vol.138 (4), p.877-889

1997

Volltextzugriff (PDF)

Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier

The Journal of biological chemistry, 1999-03, Vol.274 (11), p.7011-7017

1999

Volltextzugriff (PDF)

Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study

Brain research, 2009-10, Vol.1294, p.144-152

2009

Volltextzugriff (PDF)

P‐glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolins

Journal of neurochemistry, 2003-11, Vol.87 (4), p.1010-1023

2003

Volltextzugriff (PDF)

Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood–brain barrier

Bioorganic & medicinal chemistry letters, 2006-04, Vol.16 (8), p.2154-2157

2006

Volltextzugriff (PDF)

The MAP kinase pathway mediates transcytosis induced by TNF-α in an in vitro blood-brain barrier model

The European journal of neuroscience, 2005-08, Vol.22 (4), p.835-844

2005

Volltextzugriff (PDF)

Preferential Transfer of 2‐Docosahexaenoyl‐1‐Lysophosphatidylcholine Through an In Vitro Blood‐Brain Barrier Over Unesterified Docosahexaenoic Acid

Journal of neurochemistry, 1999-01, Vol.72 (1), p.338-345

1999

Volltextzugriff (PDF)

Down-regulation of caveolin-1 in glioma vasculature: Modulation by radiotherapy

Journal of neuroscience research, 2004-01, Vol.75 (2), p.291-299

2004

Volltextzugriff (PDF)

Inhibition of P-glycoprotein : Rapid assessment of its implication in Blood-Brain Barrier integrity and drug transport to the brain by an in vitro model of the Blood-Brain Barrier

Pharmaceutical research, 1998-07, Vol.15 (7), p.993-1000

1998

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(114)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

In vitro models for the blood–brain barrier

Prediction of drug transport through the blood-brain barrier in vivo: A comparison between two in vitro cell models

Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier

Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier

In vitro model for evaluating drug transport across the blood–brain barrier

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood–brain barrier

Effects of gamma- and hydroxypropyl-gamma-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier

Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid

Transport screening of drug cocktails through an in vitro blood-brain barrier: is it a good strategy for increasing the throughput of the discovery pipeline?

Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood–brain barrier: Use of an in vitro model

Astrocytes are mainly responsible for the polyunsaturated fatty acid enrichment in blood-brain barrier endothelial cells in vitro

Mouse syngenic in vitro blood-brain barrier model : a new tool to examine inflammatory events in cerebral endothelium

Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier

An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening

High transcytosis of melanotransferrin (P97) across the blood–brain barrier

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood-Brain Barrier

Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier

Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: An in vitro study

P‐glycoprotein in blood–brain barrier endothelial cells: interaction and oligomerization with caveolins

Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood–brain barrier

The MAP kinase pathway mediates transcytosis induced by TNF-α in an in vitro blood-brain barrier model

Preferential Transfer of 2‐Docosahexaenoyl‐1‐Lysophosphatidylcholine Through an In Vitro Blood‐Brain Barrier Over Unesterified Docosahexaenoic Acid

Down-regulation of caveolin-1 in glioma vasculature: Modulation by radiotherapy

Inhibition of P-glycoprotein : Rapid assessment of its implication in Blood-Brain Barrier integrity and drug transport to the brain by an in vitro model of the Blood-Brain Barrier

Suchergebnisse filtern